跳至主要内容
临床试验/NL-OMON56856
NL-OMON56856尚未招募不适用

Presepsin to safely reduce antibiotics in preterm infants (PRESAFE trial): a randomized controlled trial with concurrent observational cohort - PRESAFE trial

Amsterdam UMC0 个研究点目标入组 1,266 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,266

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • Infants born between 24 and 31+6 weeks gestation are eligible for enrollment.
  • Infants at high- or low-risk of early-onset sepsis will be excluded for
  • randomization and included in the observational part of the study. Infants with
  • moderate risk for EOS are randomized 1:1.

排除标准

  • Infants at low-risk or high-risk for EOS are not eligible for enrollment in the
  • randomization part of the trial.

研究者

发起方
Amsterdam UMC

相似试验